Search Results 1091-1100 of 19749 for Hepatitis+C

1. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

   Active hepatitis B or C with uncontrolled disease. NOTE: a detailed assessment of hepatitis B/C medical history and risk factors must be done at screening ...

2. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   ... hepatitis B or hepatitis C, or active tuberculosis * Patients who have undergone solid organ or allogeneic hematopoietic transplant at any time * Due to ...

3. A Study Of Belantamab Mafodotin Administered In Combination With Lenalidomide And Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, And Dexamethasone (DRd) In Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible For Autologous Stem Cell Transplantation (TI-NDMM) - Mayo Clinic

   Positive hepatitis C antibody test result or positive hepatitis C ribonucleic acid (RNA) test result at screening or within 3 months prior to first dose of ...

4. Ph 1b Study to Evaluate GSK2110183 in Combination with Bortezomib and Dexamethasone in Subjects with Multiple Myeloma - Mayo Clinic

   Subjects with a positive test for Hepatitis C (HCV) antibody are excluded, regardless of viral load. If hepatitis C antibody is positive, confirmatory tests may ...

5. Publications - John C. Cheville, M.D. - Mayo Clinic

   Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas. Clin Cancer Res. 2025 May 01; 31(9):1700-1710. View ...

6. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

   ... hepatitis B, and untreated hepatitis C. Note: A subject who is Hepatitis C antibody positive will be eligible to participate in the study if he/she has ...

7. Surgery - Doctors - Mayo Clinic

   , Hepatitis C, Wilson's disease, Hepatitis B, Hepatocellular carcinoma, Primary biliary cholangitis, Nonalcoholic fatty liver disease, Cirrhosis, Autoimmune ...

8. A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect on Disease Progression of BIIB078 in Amyotrophic Lateral Sclerosis (ALS) Patients - Mayo Clinic

   Current hepatitis C infection (defined as positive hepatitis C virus [HCV] antibody and detectable HCV RNA). Participants with positive HCV antibody and ...

9. A Study to Evaluate ADP-A2M4 with Pembrolizumab to Treat Recurrent or Metastatic Head and Neck Cancer - Mayo Clinic

   Active hepatitis C infection as demonstrated by hepatitis C RNA test. Subjects who are HCV antibody positive will be screened for HCV RNA by any RT-PCR or ...

10. A Study to Evaluate the Effectiveness and Safety of CC-90001 in Subjects With Non-alcoholic Steatohepatitis (NASH) and Liver Fibrosis - Mayo Clinic

    Hepatitis and fibrosis more likely related to etiologies other than ... History of hepatitis B and/or hepatitis C. History of malignancy. Exceptions ...